SOLIGENIX, INC. (SNGX)

(10% Negative) SOLIGENIX, INC. (SNGX) Announces Delay in halt Trials for futility Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment